Masimo ROA 2012-2025 | MASI
Current and historical return on assets (ROA) values for Masimo (MASI) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Masimo ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.57B | $1.82B | -24.95% |
| 2025-06-30 | $-0.46B | $2.40B | -17.68% |
| 2025-03-31 | $-0.50B | $2.29B | -18.16% |
| 2024-12-31 | $-0.31B | $2.63B | -10.55% |
| 2024-09-30 | $0.08B | $3.09B | 2.64% |
| 2024-06-30 | $0.08B | $2.89B | 2.69% |
| 2024-03-31 | $0.08B | $2.96B | 2.67% |
| 2023-12-31 | $0.08B | $3.04B | 2.70% |
| 2023-09-30 | $0.09B | $3.00B | 2.89% |
| 2023-06-30 | $0.12B | $3.01B | 3.74% |
| 2023-03-31 | $0.12B | $3.12B | 3.82% |
| 2022-12-31 | $0.14B | $3.21B | 5.17% |
| 2022-09-30 | $0.17B | $3.06B | 6.97% |
| 2022-06-30 | $0.19B | $2.96B | 8.96% |
| 2022-03-31 | $0.22B | $1.91B | 12.31% |
| 2021-12-31 | $0.23B | $1.89B | 13.21% |
| 2021-09-30 | $0.23B | $1.77B | 13.73% |
| 2021-06-30 | $0.22B | $1.68B | 13.30% |
| 2021-03-31 | $0.23B | $1.60B | 13.75% |
| 2020-12-31 | $0.24B | $1.71B | 14.69% |
| 2020-09-30 | $0.22B | $1.71B | 14.28% |
| 2020-06-30 | $0.22B | $1.64B | 15.26% |
| 2020-03-31 | $0.21B | $1.48B | 15.59% |
| 2019-12-31 | $0.20B | $1.40B | 15.32% |
| 2019-09-30 | $0.19B | $1.31B | 15.58% |
| 2019-06-30 | $0.20B | $1.23B | 17.00% |
| 2019-03-31 | $0.20B | $1.18B | 17.76% |
| 2018-12-31 | $0.19B | $1.16B | 18.44% |
| 2018-09-30 | $0.14B | $1.10B | 14.05% |
| 2018-06-30 | $0.12B | $1.01B | 12.53% |
| 2018-03-31 | $0.12B | $0.95B | 13.02% |
| 2017-12-31 | $0.13B | $0.91B | 13.95% |
| 2017-09-30 | $0.36B | $0.91B | 41.02% |
| 2017-06-30 | $0.35B | $0.90B | 43.41% |
| 2017-03-31 | $0.34B | $0.88B | 45.70% |
| 2016-12-31 | $0.31B | $0.82B | 46.50% |
| 2016-09-30 | $0.11B | $0.64B | 17.85% |
| 2016-06-30 | $0.10B | $0.60B | 16.81% |
| 2016-03-31 | $0.09B | $0.62B | 15.09% |
| 2015-12-31 | $0.08B | $0.60B | 14.19% |
| 2015-09-30 | $0.08B | $0.58B | 13.90% |
| 2015-06-30 | $0.08B | $0.58B | 13.48% |
| 2015-03-31 | $0.07B | $0.58B | 13.08% |
| 2014-12-31 | $0.07B | $0.57B | 14.21% |
| 2014-09-30 | $0.06B | $0.53B | 12.65% |
| 2014-06-30 | $0.06B | $0.50B | 13.59% |
| 2014-03-31 | $0.07B | $0.46B | 15.09% |
| 2013-12-31 | $0.06B | $0.44B | 14.04% |
| 2013-09-30 | $0.06B | $0.43B | 16.12% |
| 2013-06-30 | $0.06B | $0.40B | 15.80% |
| 2013-03-31 | $0.06B | $0.39B | 16.22% |
| 2012-12-31 | $0.06B | $0.38B | 16.30% |
| 2012-09-30 | $0.06B | $0.41B | 16.14% |
| 2012-06-30 | $0.06B | $0.38B | 16.79% |
| 2012-03-31 | $0.06B | $0.38B | 16.85% |
| 2011-12-31 | $0.06B | $0.37B | 18.03% |
| 2011-09-30 | $0.07B | $0.37B | 19.35% |
| 2011-06-30 | $0.07B | $0.35B | 20.35% |
| 2011-03-31 | $0.06B | $0.33B | 20.22% |
| 2010-12-31 | $0.07B | $0.31B | 23.76% |
| 2010-09-30 | $0.07B | $0.33B | 22.27% |
| 2010-06-30 | $0.07B | $0.30B | 21.18% |
| 2010-03-31 | $0.07B | $0.29B | 20.63% |
| 2009-12-31 | $0.05B | $0.36B | 16.15% |
| 2009-09-30 | $0.04B | $0.34B | 12.16% |
| 2009-06-30 | $0.04B | $0.32B | 12.83% |
| 2009-03-31 | $0.04B | $0.31B | 12.86% |
| 2008-12-31 | $0.03B | $0.29B | 12.28% |
| 2008-09-30 | $0.04B | $0.27B | 17.87% |
| 2008-06-30 | $0.04B | $0.25B | 16.19% |
| 2008-03-31 | $0.03B | $0.23B | 13.92% |
| 2007-12-31 | $0.02B | $0.24B | 14.49% |
| 2007-09-30 | $0.02B | $0.23B | 15.04% |
| 2007-06-30 | $0.01B | $0.17B | 27.59% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.630B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $232.458B | 27.62 |
| Intuitive Surgical (ISRG) | United States | $191.785B | 75.04 |
| IDEXX Laboratories (IDXX) | United States | $57.123B | 56.73 |
| Edwards Lifesciences (EW) | United States | $48.948B | 32.82 |
| IQVIA Holdings (IQV) | United States | $40.477B | 22.57 |
| Alcon (ALC) | Switzerland | $39.075B | 26.33 |
| Mettler-Toledo (MTD) | United States | $29.838B | 34.91 |
| DexCom (DXCM) | United States | $27.122B | 37.39 |
| STERIS (STE) | Ireland | $26.367B | 27.22 |
| Waters (WAT) | United States | $23.067B | 30.50 |
| Coloplast (CLPBY) | Denmark | $20.080B | 34.27 |
| Hologic (HOLX) | United States | $16.713B | 17.56 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.207B | 0.00 |
| Penumbra (PEN) | United States | $13.737B | 96.63 |
| Globus Medical (GMED) | United States | $12.510B | 26.26 |
| Glaukos (GKOS) | United States | $6.906B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.194B | 19.68 |
| TransMedics (TMDX) | United States | $4.900B | 58.04 |
| Teleflex (TFX) | United States | $4.552B | 7.25 |
| LivaNova (LIVN) | United Kingdom | $3.392B | 18.32 |
| Veracyte (VCYT) | United States | $3.286B | 37.45 |
| Integer Holdings (ITGR) | United States | $3.006B | 14.11 |
| Alphatec Holdings (ATEC) | United States | $2.635B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.510B | 23.48 |
| Artivion (AORT) | United States | $2.056B | 94.33 |
| Nihon Kohden (NHNKY) | Japan | $2.038B | 17.79 |
| UFP Technologies (UFPT) | United States | $2.009B | 26.53 |
| PROCEPT BioRobotics (PRCT) | United States | $1.698B | 0.00 |
| AxoGen (AXGN) | United States | $1.431B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.367B | 0.00 |
| IRadimed (IRMD) | United States | $1.298B | 61.82 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.967B | 5.24 |
| Pulse Biosciences (PLSE) | United States | $0.966B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.814B | 0.00 |
| SiBone (SIBN) | United States | $0.738B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.680B | 39.56 |
| Pacific Biosciences Of California (PACB) | United States | $0.667B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.604B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.573B | 11.43 |
| NeuroPace (NPCE) | United States | $0.564B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.556B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.490B | 13.52 |
| OrthoPediatrics (KIDS) | United States | $0.460B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.431B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.416B | 0.00 |
| RxSight (RXST) | United States | $0.403B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.366B | 61.00 |
| Sight Sciences (SGHT) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Spectral Diagnostics (EDTXF) | Canada | $0.293B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.211B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.185B | 0.00 |
| Inogen (INGN) | United States | $0.170B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.168B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.167B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.144B | 0.00 |
| LENSAR (LNSR) | United States | $0.142B | 0.00 |
| CVRx (CVRX) | United States | $0.137B | 0.00 |
| Solana (HSDT) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.130B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.129B | 0.00 |
| Hyperfine (HYPR) | United States | $0.117B | 0.00 |
| Accuray (ARAY) | United States | $0.095B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| DarioHealth (DRIO) | United States | $0.084B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.067B | 0.00 |
| Positron (POSC) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.031B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.020B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 10.55 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |